 | Haloperidol | IC50 | 0.06 [1], 10.0 [2] |
| Haloperidol | Ki | 4.4 [1], 4.6 [2], 10.4 [3], 18.0 [4] |
 | Clozapine | IC50 | 450.0 [1] |
| Clozapine | Ki | 240.0 [1], 242.0 [2], 319.0 [3], 513.0 [4] |
 | Quinpirole | Ki | 23.99 [1], 24.0 [2], 420.0 [3] |
 | 2-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine | Ki | 5300.0 [1] |
 | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | IC50 | 3.0 [1], 13.0 [2], 56.0 [3] |
| 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 0.92 [1] |
 | N-[4-[2-(6-Cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide | Ki | 11.2 [1] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | IC50 | 4.94 [1] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 0.5 [1], 0.8 [2], 2.6 [3] |
 | Olanzapine | Ki | 39.0 [1], 43.0 [2] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide | IC50 | 5.0 [1], 14.4 [2] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide | Ki | 2.0 [1], 2.7 [2] |
 | Risperidone | Ki | 16.0 [1], 31.0 [2] |
 | 3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine | Ki | 2310.0 [1] |
 | 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine | Ki | 5000.0 [1] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | IC50 | 9.01 [1] |
| N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 0.8 [1], 1.5 [2], 4.3 [3] |
 | Spiperone | IC50 | 0.36 [1], 93.2 [2], 97.0 [3] |
| Spiperone | Ki | 1.31 [1] |
 | US8748608, 34 Enantiomer A | IC50 | 29.9 [1], 30.0 [2], 495.0 [3] |
 | N-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]imidazo[1,2-a]pyridine-2-carboxamide | IC50 | 0.6 [1], 1.3 [2], 157.0 [3] |
 | Pramipexole | Ki | 0.72 [1], 0.88 [2], 38.0 [3] |
 | 7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | Ki | 1.4 [1], 2.9 [2] |
 | 3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole | IC50 | 90.4 [1] |
 | CID 11477180 | IC50 | 3.0 [1], 3.01 [2] |
| CID 11477180 | Ki | 0.7 [1], 2.11 [2] |
 | 7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol | Ki | 0.79 [1] |
 | N-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]-5-[(dimethylamino)methyl]imidazo[1,2-a]pyridine-2-carboxamide | IC50 | 29.0 [1] |
 | N-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]-3-[(dimethylamino)methyl]imidazo[1,2-a]pyridine-2-carboxamide | IC50 | 7.2 [1] |
 | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | IC50 | 0.22 [1] |
| N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | Ki | 0.19 [1], 0.23 [2], 0.27 [3] |
 | (R)-N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide | IC50 | 18.2 [1] |
| (R)-N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide | Ki | 0.53 [1], 1.12 [2], 2.9 [3] |
 | 4-[3-(4-Chlorophenyl)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 0.71 [1] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)but-2-enyl)-9H-fluorene-2-carboxamide | IC50 | 173.0 [1] |
| N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)but-2-enyl)-9H-fluorene-2-carboxamide | Ki | 1.5 [1], 5.0 [2], 5.9 [3] |
 | (S)-7-Dipropylamino-5,6,7,8-tetrahydro-indolizine-3-carbaldehyde | Ki | 5.25 [1], 5.3 [2], 150.0 [3] |
 | N-[(E)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]but-2-enyl]-1-benzothiophene-2-carboxamide | IC50 | 9.62 [1] |
| N-[(E)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]but-2-enyl]-1-benzothiophene-2-carboxamide | Ki | 1.1 [1], 1.11 [2], 3.3 [3], 1770.0 [4] |
 | N-[(E)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]but-2-enyl]-1-benzofuran-2-carboxamide | IC50 | 18.7 [1] |
| N-[(E)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]but-2-enyl]-1-benzofuran-2-carboxamide | Ki | 2.1 [1], 2.11 [2], 7.11 [3] |
 | Sulpiride | IC50 | 66.22 [1], 560.0 [2] |
| Sulpiride | Ki | 8.0 [1], 57.0 [2], 120.0 [3] |
 | Ziprasidone | Ki | 6.31 [1], 7.2 [2], 7.5 [3], 10.0 [4] |
 | (+)-Butaclamol | IC50 | 1.6 [1], 16.0 [2] |
| (+)-Butaclamol | Ki | 0.04 [1] |
 | Butaclamol | IC50 | 1.2 [1], 1.9 [2], 6.6 [3], 10.0 [4] |
| Butaclamol | Ki | 6.39 [1] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide | IC50 | 6.31 [1] |
| N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide | Ki | 0.4 [1], 0.5 [2], 2.33 [3] |
 | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | IC50 | 2.39 [1] |
| N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 0.92 [1], 1.1 [2], 1.12 [3] |
 | N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-but-2-enyl}-benzamide | IC50 | 7.71 [1], 7.72 [2] |
| N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-but-2-enyl}-benzamide | Ki | 0.8 [1], 6.02 [2] |
 | N-[4-[(4-Ethynylcyclohex-3-en-1-yl)-propylamino]butyl]-4-phenylbenzamide | Ki | 0.2 [1], 0.21 [2], 0.78 [3], 20.0 [4], 870.0 [5] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]quinoxaline-2-carboxamide | IC50 | 26.8 [1], 26.9 [2] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]quinoxaline-2-carboxamide | Ki | 1.4 [1], 10.6 [2] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-3-fluorobutyl]-1-benzofuran-2-carboxamide | IC50 | 430.0 [1] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-3-fluorobutyl]-1-benzofuran-2-carboxamide | Ki | 5.4 [1], 6.1 [2], 10.0 [3], 31.5 [4] |
 | 2-[5-[4-(4-Chlorophenyl)piperazin-1-yl]pentyl]pyrazolo[1,5-a]pyridine | Ki | 220.0 [1], 370.0 [2], 530.0 [3], 1100.0 [4], 1900.0 [5] |
 | Apomorphine | Ki | 2.6 [1], 7.8 [2], 10.0 [3], 17.0 [4] |
 | Ropinirole | Ki | 2.9 [1], 19.0 [2], 36.31 [3], 61.0 [4] |
 | Preclamol | Ki | 25.0 [1], 25.12 [2], 132.0 [3] |
 | Cariprazine | Ki | 0.09 [1], 0.1 [2], 0.27 [3] |
 | 5-OH-Dpat | Ki | 0.66 [1], 1.36 [2], 4.4 [3] |
 | (1S,2R)-5-Methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine | Ki | 4.0 [1], 4.2 [2], 12.59 [3] |
 | Sumanirole | Ki | 546.0 [1], 573.0 [2], 2333.0 [3], 6330.0 [4] |
 | 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole | Ki | 480.0 [1], 770.0 [2] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide | Ki | 0.66 [1], 1.4 [2] |
 | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-6-ol | Ki | 47.0 [1], 47.5 [2] |
 | 4-Methyl-5-[4-methyl-5-[3-[1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexan-3-yl]propylsulfanyl]-1,2,4-triazol-3-yl]-1,3-oxazole | Ki | 0.5 [1] |
 | N-[(3S)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-3-hydroxybutyl]-1H-indole-2-carboxamide | IC50 | 6.6 [1] |
| N-[(3S)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-3-hydroxybutyl]-1H-indole-2-carboxamide | Ki | 3.9 [1], 16.6 [2] |
 | N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butyl}-4-iodo-benzamide | IC50 | 31.7 [1] |
| N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butyl}-4-iodo-benzamide | Ki | 1.6 [1], 3.0 [2] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-5-fluoro-1H-indole-2-carboxamide | IC50 | 52.0 [1], 52.4 [2] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-5-fluoro-1H-indole-2-carboxamide | Ki | 0.28 [1], 0.52 [2] |
Calculator
